This study provides empirical evidence on whether polypharmacy and potentially inappropriate prescription medications (PIRx, as defined by the 2003 Beers criteria) increase the likelihood of functional decline among community-dwelling older adults with dementia. Data were from the National Alzheimer's Coordinating Center, Uniform Data Set (9/2005-9/2009). Study sample included 1994 community-dwelling participants aged ≥65 with dementia at baseline. Results showed that participants having ≥5 medications were more likely to have functional decline than participants having <5 medications. However, the increased likelihood was only apparent in participants who did not have PIRx. Instead of magnifying the associated risk as hypothesized, PIRx appeared to have a protective effect albeit marginally statistically significant. Therefore, increased medication burden may be associated with functional decline in community-dwelling older adults with dementia who are not prescribed with PIRx. More research is needed to understand which classes of medications have the most deleterious effect on this population. © 2011 SAGE Publications.
CITATION STYLE
Lau, D. T., Mercaldo, N. D., Shega, J. W., Rademaker, A., & Weintraub, S. (2011). Functional decline associated with polypharmacy and potentially inappropriate medications in community-dwelling older adults with dementia. American Journal of Alzheimer’s Disease and Other Dementias, 26(8), 606–615. https://doi.org/10.1177/1533317511432734
Mendeley helps you to discover research relevant for your work.